Porto‐Sinusoidal Vascular Disorder‐Spectrum Portal Venopathy as a Structural Substrate for Portal Hypertension in Anti‐Centromere Antibody‐Positive Primary Biliary Cholangitis
Open Access
- 15 September 2026
- journal article
- research article
- Published by Wiley in Pathology International
- Vol. 76 (9) , e70179
Abstract
Anti‐centromere antibody (ACA) positivity in primary biliary cholangitis (PBC) has been associated with a portal hypertension‐dominant clinical trajectory, even without advanced fibrosis. This study investigated whether porto‐sinusoidal vascular disorder (PSVD)‐spectrum portal venopathy may underlie this phenotype. This retrospective case‐series study included three ACA‐positive PBC‐spectrum patients who underwent liver biopsy. The clinical characteristics, imaging findings, liver and spleen stiffness, hepatic venography, and hepatic venous pressure gradient (HVPG) were evaluated. Liver specimens were assessed for PSVD‐spectrum portal venopathy and PBC‐related bile duct injury. All patients presented with PSVD‐spectrum portal venopathy on liver biopsy; PBC‐defining bile duct lesions were present in two patients, and the presence of ductular reaction was suggestive of a biliary disease but not diagnostic for PBC in one patient. All patients had manifestations of portal hypertension with preserved liver synthetic function and noncirrhotic liver stiffness. The portal sandwich sign was present in all patients. When available, spleen stiffness was markedly elevated, indicating spleen–liver stiffness dissociation. HVPG was heterogeneous, with normal values in two patients and marked elevation in one patient. In summary, PSVD‐spectrum portal venopathy may contribute to disproportionate portal hypertension in ACA‐positive PBC‐spectrum patients but constitutes a diagnostic gray zone because PBC is defined as exclusionary in PSVD definitions.Keywords
This publication has 24 references indexed in Scilit:
- A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPFJournal of Hepatology, 2026
- Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcomeJournal of Hepatology, 2024
- Porto-sinusoidal vascular disorderJournal of Hepatology, 2022
- Baveno VII – Renewing consensus in portal hypertensionJournal of Hepatology, 2022
- Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver DiseasesHepatology, 2018
- Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosisHepatology, 2006
- Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti–endothelial cell antibodiesArthritis & Rheumatism, 2006
- Association of Clonally Expanded T Cells With the Syndrome of Primary Biliary Cirrhosis and Limited SclerodermaHepatology, 1999
- Still Immunodetectable Nuclear RNPs Are Extruded from the Cytoplasm of Spontaneously Apoptotic ThymocytesExperimental Cell Research, 1997
- Abnormal T Cell Activation and Skewed T Cell Receptor Vβ Repertoire Usage in Japanese Patients with Idiopathic Portal HypertensionClinical Immunology and Immunopathology, 1995